Literature DB >> 6287138

Physiological effects of high dose naloxone administration to normal adults.

M R Cohen, R M Cohen, D Pickar, D L Murphy, W E Bunney.   

Abstract

The intravenous bolus administration of high doses of the opioid receptor antagonist naloxone (in the mg./kg. range) to normal adults produced dose-dependent increases in systolic blood pressure and respiratory rate. No significant alterations in other physiological processes were found although there were trends for increases in oral temperature and pulse rate with increasing dose. These results suggest the involvement of an endogenous opioid system in the tonic regulation of human systolic blood pressure and respiration and the probable inadequacy of doses of naloxone previously utilized in human studies to effect complete blockade of endogenous opioid systems.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287138     DOI: 10.1016/0024-3205(82)90443-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Influence of naloxone on the effects of high frequency transcutaneous electrical nerve stimulation in angina pectoris induced by atrial pacing.

Authors:  C Mannheimer; H Emanuelsson; F Waagstein; C Wilhelmsson
Journal:  Br Heart J       Date:  1989-07

3.  The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.

Authors:  G Boachie-Ansah; R Sitsapesan; K A Kane; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Effects of morphine on cardiovascular responses to acute myocardial ischaemia in rats.

Authors:  M Y Chan; S Dai; W W Ko
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

Review 5.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

6.  Human cardiovascular reactions to simulated hypovolaemia, modified by the opiate antagonist naloxone.

Authors:  N Foldager; F Bonde-Petersen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

7.  Does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? A placebo-controlled, double-blind, randomized, cross-over study.

Authors:  Manuel P Pereira; Mads U Werner; Thomas K Ringsted; Michael C Rowbotham; Bradley K Taylor; Joergen B Dahl
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Effects of target-controlled infusion of high-dose naloxone on pain and hyperalgesia in a human thermal injury model: a study protocol: A randomized, double-blind, placebo-controlled, crossover trial with an enriched design.

Authors:  Anders D Springborg; Elisabeth K Jensen; Bradley K Taylor; Mads U Werner
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

9.  Endogenous Opioid-Masked Latent Pain Sensitization: Studies from Mouse to Human.

Authors:  Manuel P Pereira; Renee R Donahue; Jørgen B Dahl; Marianne Werner; Bradley K Taylor; Mads U Werner
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.

Authors:  M P Pereira; M U Werner; J B Dahl; Manuel Pedro Pereira; Mads Utke Werner; Joergen Berg Dahl
Journal:  Trials       Date:  2015-11-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.